vs
FONAR CORP（FONR）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是FONAR CORP的1.3倍（$32.3M vs $25.5M），RBB Bancorp净利率更高（31.5% vs 8.0%，领先23.4%），RBB Bancorp同比增速更快（12.6% vs 2.4%），RBB Bancorp自由现金流更多（$42.6M vs $-227.0K），过去两年RBB Bancorp的营收复合增速更高（7.0% vs -0.3%）
FONAR是一家专业医疗技术企业，专注于设计、制造及销售包括立式、开放式在内的创新磁共振成像（MRI）设备，主要服务美国的医院、影像诊断中心及医疗机构，为临床诊断提供高精度扫描解决方案。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
FONR vs RBB — 直观对比
营收规模更大
RBB
是对方的1.3倍
$25.5M
营收增速更快
RBB
高出10.2%
2.4%
净利率更高
RBB
高出23.4%
8.0%
自由现金流更多
RBB
多$42.8M
$-227.0K
两年增速更快
RBB
近两年复合增速
-0.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.5M | $32.3M |
| 净利润 | $2.1M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | 13.5% | 39.5% |
| 净利率 | 8.0% | 31.5% |
| 营收同比 | 2.4% | 12.6% |
| 净利润同比 | 4.7% | 132.1% |
| 每股收益（稀释后） | — | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FONRRBB
| Q4 25 | $25.5M | $32.3M | ||
| Q3 25 | $26.0M | $32.6M | ||
| Q2 25 | $27.3M | $35.8M | ||
| Q1 25 | $27.2M | $28.5M | ||
| Q4 24 | $24.9M | $28.7M | ||
| Q3 24 | $25.0M | $30.3M | ||
| Q2 24 | $25.9M | $27.5M | ||
| Q1 24 | $25.7M | $28.2M |
净利润FONRRBB
| Q4 25 | $2.1M | $10.2M | ||
| Q3 25 | $2.3M | $10.1M | ||
| Q2 25 | $729.3K | $9.3M | ||
| Q1 25 | $2.5M | $2.3M | ||
| Q4 24 | $2.0M | $4.4M | ||
| Q3 24 | $3.1M | $7.0M | ||
| Q2 24 | $830.4K | $7.2M | ||
| Q1 24 | $1.9M | $8.0M |
营业利润率FONRRBB
| Q4 25 | 13.5% | 39.5% | ||
| Q3 25 | 14.1% | 40.7% | ||
| Q2 25 | 5.3% | 36.1% | ||
| Q1 25 | 15.2% | 11.2% | ||
| Q4 24 | 11.9% | 17.6% | ||
| Q3 24 | 21.0% | 31.6% | ||
| Q2 24 | 7.4% | 35.6% | ||
| Q1 24 | 16.8% | 39.9% |
净利率FONRRBB
| Q4 25 | 8.0% | 31.5% | ||
| Q3 25 | 8.7% | 31.2% | ||
| Q2 25 | 2.7% | 26.1% | ||
| Q1 25 | 9.2% | 8.0% | ||
| Q4 24 | 7.9% | 15.3% | ||
| Q3 24 | 12.6% | 23.1% | ||
| Q2 24 | 3.2% | 26.4% | ||
| Q1 24 | 7.3% | 28.4% |
每股收益（稀释后）FONRRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | — | $0.59 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | — | $0.39 | ||
| Q2 24 | — | $0.39 | ||
| Q1 24 | — | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $121.0K | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $176.9M | $523.4M |
| 总资产 | $217.2M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资FONRRBB
| Q4 25 | $121.0K | $212.3M | ||
| Q3 25 | $122.0K | $234.9M | ||
| Q2 25 | $56.5M | $191.9M | ||
| Q1 25 | $123.0K | $238.8M | ||
| Q4 24 | $121.0K | $257.7M | ||
| Q3 24 | $136.0K | $349.4M | ||
| Q2 24 | $56.5M | $252.8M | ||
| Q1 24 | $134.0K | — |
总债务FONRRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | $66.9K | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益FONRRBB
| Q4 25 | $176.9M | $523.4M | ||
| Q3 25 | $174.9M | $514.3M | ||
| Q2 25 | $172.6M | $517.7M | ||
| Q1 25 | $171.9M | $510.3M | ||
| Q4 24 | $169.8M | $507.9M | ||
| Q3 24 | $168.7M | $509.7M | ||
| Q2 24 | $166.0M | $511.3M | ||
| Q1 24 | $165.8M | $514.0M |
总资产FONRRBB
| Q4 25 | $217.2M | $4.2B | ||
| Q3 25 | $218.4M | $4.2B | ||
| Q2 25 | $216.9M | $4.1B | ||
| Q1 25 | $214.9M | $4.0B | ||
| Q4 24 | $208.0M | $4.0B | ||
| Q3 24 | $212.3M | $4.0B | ||
| Q2 24 | $214.2M | $3.9B | ||
| Q1 24 | $209.6M | $3.9B |
负债/权益比FONRRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | 0.00× | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $171.0K | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-227.0K | $42.6M |
| 自由现金流率自由现金流/营收 | -0.9% | 131.8% |
| 资本支出强度资本支出/营收 | 1.6% | 2.5% |
| 现金转化率经营现金流/净利润 | 0.08× | 4.26× |
| 过去12个月自由现金流最近4个季度 | $5.7M | $73.5M |
8季度趋势，按日历期对齐
经营现金流FONRRBB
| Q4 25 | $171.0K | $43.4M | ||
| Q3 25 | $1.7M | $2.1M | ||
| Q2 25 | $4.2M | $21.7M | ||
| Q1 25 | $3.1M | $7.8M | ||
| Q4 24 | $2.2M | $58.5M | ||
| Q3 24 | $1.7M | $24.5M | ||
| Q2 24 | $4.6M | $11.7M | ||
| Q1 24 | $2.8M | $4.8M |
自由现金流FONRRBB
| Q4 25 | $-227.0K | $42.6M | ||
| Q3 25 | $-177.0K | $1.8M | ||
| Q2 25 | $3.6M | $21.6M | ||
| Q1 25 | $2.6M | $7.6M | ||
| Q4 24 | $1.5M | $57.7M | ||
| Q3 24 | $-148.0K | $24.2M | ||
| Q2 24 | $4.2M | $11.5M | ||
| Q1 24 | $2.6M | $4.7M |
自由现金流率FONRRBB
| Q4 25 | -0.9% | 131.8% | ||
| Q3 25 | -0.7% | 5.4% | ||
| Q2 25 | 13.1% | 60.2% | ||
| Q1 25 | 9.4% | 26.7% | ||
| Q4 24 | 6.0% | 201.0% | ||
| Q3 24 | -0.6% | 80.0% | ||
| Q2 24 | 16.1% | 42.0% | ||
| Q1 24 | 10.2% | 16.6% |
资本支出强度FONRRBB
| Q4 25 | 1.6% | 2.5% | ||
| Q3 25 | 7.2% | 1.1% | ||
| Q2 25 | 2.4% | 0.3% | ||
| Q1 25 | 2.2% | 0.6% | ||
| Q4 24 | 3.0% | 2.7% | ||
| Q3 24 | 7.2% | 0.8% | ||
| Q2 24 | 1.6% | 0.5% | ||
| Q1 24 | 0.7% | 0.5% |
现金转化率FONRRBB
| Q4 25 | 0.08× | 4.26× | ||
| Q3 25 | 0.75× | 0.21× | ||
| Q2 25 | 5.79× | 2.32× | ||
| Q1 25 | 1.26× | 3.39× | ||
| Q4 24 | 1.14× | 13.34× | ||
| Q3 24 | 0.53× | 3.50× | ||
| Q2 24 | 5.54× | 1.61× | ||
| Q1 24 | 1.50× | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
RBB
暂无分部数据
